PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, October 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 127 Dimensions

Readers on

mendeley: 76 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 3,807 followers.

PSMA targeted radioligandtherapy in metastatic CRPC after chemotherapy, abiraterone and/or enzalutamide. https://t.co/7XwsWriMJh

Reply Repost Favourite

https://t.co/VR4PxHd17D

Reply Repost Favourite

https://t.co/JwtbElBklc

Reply Repost Favourite